Myung Soo Kang

Title: Myung Soo Kang: Innovator in Antibacterial Proteins

Introduction

Myung Soo Kang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibacterial proteins. His work focuses on innovative solutions to combat bacterial infections, which is a growing concern in modern medicine.

Latest Patents

Myung Soo Kang holds a patent for an antibacterial protein known as EFAL-2. This protein is derived from the bacteriophage Ent-FAP-4 and possesses bacteriolytic abilities. The patent details the amino acid sequence represented by SEQ ID NO: 2 and describes a pharmaceutical composition that includes this protein as an active ingredient. This composition is intended for the prevention and treatment of diseases caused by bacterial infections.

Career Highlights

Kang is associated with Intron Biotechnology, Inc., where he continues to advance his research in the field of antibacterial agents. His work has garnered attention for its potential applications in medical treatments and pharmaceutical developments.

Collaborations

Throughout his career, Myung Soo Kang has collaborated with notable colleagues, including Seong Jun Yoon and Soo Youn Jun. These partnerships have contributed to the advancement of his research and the successful development of innovative solutions in biotechnology.

Conclusion

Myung Soo Kang's contributions to the field of antibacterial proteins highlight his role as an influential inventor in biotechnology. His patented work on EFAL-2 represents a significant step forward in the fight against bacterial infections.